JSB Market Research: Xalkori (Non-Small Cell Lung Cancer) - Forecast and Market Analysis to 2022
2014-06-24 10
Non-Small Cell Lung Cancer (NSCLC) is the most common lung cancer, and the second-most common cancer in men and women. Historically, the treatment paradigm has centered around chemotherapy.
